In 138 adults undergoing liver transplantation, prophylactic tranexamic acid did not significantly reduce major bleeding within 24 hours vs placebo (48.5% vs 62.9%; RR 0.77, 95% CI 0.56-1.04). Secondary outcomes: fewer transfusions, shorter stay; no rise in thrombosis or death.
RCTn = 138
Martinelli et al. The prophylactic use of tranexamic acid in orthotopic liver transplantation: A randomized placebo-controlled study